KENDALL BELL: Open Payments
NPI 1770115511 · OXFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 12 payments from 11 companies in 2025. Trend: 2023 $19 · 2024 $190 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $151 |
| Lundbeck LLC | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
Products named: COBALT DR MRI SURESCAN, REXULTI, SPRAVATO, VRAYLAR, ZENPEP, XIFAXAN, The Cologuard Plus Collection Kit, MOUNJARO.
Industry payments across MI — which companies pay providers there.
